National Atomic Company Kazatomprom JSC (KZAP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Oct, 2026Executive summary
H1 2024 revenue rose 13% to KZT 701.1bn and net profit increased 27% to KZT 283.2bn, while the value-over-volume strategy continued.
Supply discipline persisted amid sulfuric acid constraints, development delays and a tightening long-term uranium supply-demand outlook.
2024 production guidance increased; 2025 guidance was revised below earlier plans because of sulfuric acid uncertainty and construction delays, while sales commitments remained secure.
CFO Sultan Temirbayev resigned; Marat Tulebayev was nominated as his successor, pending corporate approval.
Financial highlights
Consolidated revenue was KZT 701.1bn (+13% YoY), net profit KZT 283.2bn (+27%) and adjusted EBITDA KZT 377.0bn (+14%).
Operating profit declined 10% to KZT 226.7bn as cost of sales rose 38%, mainly from higher uranium purchase costs.
Mining-entity CAPEX on a 100% basis reached KZT 125.9bn, up 64% YoY.
FY2023 dividend of KZT 315bn ($673m, or $2.60/GDR) was paid in June 2024; stated yield was 6.5%.
Outlook and guidance
2024 production guidance rose to 22,500–23,500 tU on a 100% basis and 11,600–12,600 tU attributable, from initial ranges of 21,000–22,500 and 10,900–11,900 tU.
2025 production is expected at 25,000–26,500 tU on a 100% basis, about 12% above 2024 guidance but below earlier plans; no 2026 volume decision has been made.
2024 sales guidance remains 15,500–16,500 tU; revenue guidance is KZT 1,700–1,800bn.
2024 mining-entity CAPEX guidance increased to KZT 260–280bn; attributable C1 and all-in sustaining cost guidance is $16.50–$18.00/lb and $27.00–$28.50/lb.
Uranium MET rises to 9% in 2025; from 2026, rates differentiate by production under each agreement and uranium price.
Latest events from National Atomic Company Kazatomprom JSC
- Higher 9M output and prices; 2026 guidance unchanged as uranium markets tightened.KZAP
Q3 2026 TU - Higher realized prices and raised sales guidance offset disciplined, lower production volumes.KZAP
H1 2023 - Higher uranium prices lifted FY2023 revenue as 2024 guidance targets increased output and investment.KZAP
H2 2023 - Revenue up 9% YoY, net profit down 9%, with higher costs and strong uranium leadership.KZAP
Q2 2026 - Production, sales, and realized prices increased in 1H2026 amid robust uranium market demand.KZAP
Q2 2026 TU - Revenue and profit fell on lower uranium sales, but a major dividend was approved.KZAP
Q1 2026 - Production up, sales down, prices higher; 2026 guidance steady amid robust nuclear demand.KZAP
Q1 2026 TU - Revenue fell but operating profit and production rose, with strong liquidity and growth plans.KZAP
Q2 2025 - 2024 net profit nearly doubled on uranium price strength and one-off gains; 2025 outlook robust.KZAP
Q4 2024